Blog

New Intensive Therapy for MS leads to better outcomes despite concerns of high risks

New Intensive Therapy for MS leads to better outcomes despite concerns of high risks
Posted on 21 Feb 2019 by Enviva Care

New findings by researchers at Cardiff University suggest that intensive therapy during the early stages of multiple sclerosis (MS) leads to better long-term outcomes for patients, despite it often being viewed as a riskier option than other first-line treatments.


New UK guidelines for pregnancy in Multiple Sclerosis

New UK guidelines for pregnancy in Multiple Sclerosis
Posted on 19 Feb 2019 by Enviva Care

The MS Trust has teamed up with a group of experienced health professionals to develop guidelines to support discussions between health professionals and people with multiple sclerosis (MS) regarding pregnancy.


Talks resume on life-saving drug for cystic fibrosis

Talks resume on life-saving drug for cystic fibrosis
Posted on 14 Feb 2019 by Enviva Care

Britain’s cystic fibrosis (CF) sufferers have received fresh hope of receiving a life-saving drug after officials agreed to sit down together to try and end a funding deadlock.


Top-level sport increases risk of Motor Neurone Disease

Top-level sport increases risk of Motor Neurone Disease
Posted on 11 Feb 2019 by Enviva Care

Experts are calling for more research to be conducted into the link between Motor Neurone Disease (MND) and top-level sport after the results of a recent study.


Duchenne muscular dystrophy mice restored to almost full strength thanks to new study

Duchenne muscular dystrophy mice restored to almost full strength thanks to new study
Posted on 7 Feb 2019 by Enviva Care

A new study has found a method which could restore muscle strength in those suffering from Duchenne muscular dystrophy (DMD).


Researchers move closer to giving voice back to those who can’t speak

Researchers move closer to giving voice back to those who can’t speak
Posted on 4 Feb 2019 by Enviva Care

Scientists have taken a step closer to being able to provide a ‘new voice’ for people who are unable to verbally communicate, such as those living with amyotrophic lateral sclerosis (ALS) or recovering from strokes.


Could a bacterium be responsible for severe forms of cystic fibrosis?

Could a bacterium be responsible for severe forms of cystic fibrosis?
Posted on 31 Jan 2019 by Enviva Care

A recent retrospective meta-analysis has found that Pseudomonas aeruginosa (P. aeruginosa) – a bacterium that can cause impaired lung function – may be the cause for more serious forms of cystic fibrosis (CF).


New study sheds light on changes in brain cells in people with MS

New study sheds light on changes in brain cells in people with MS
Posted on 28 Jan 2019 by Enviva Care

New research has offered fresh insights into the types of cells found in the brains of people with multiple sclerosis (MS), which could help develop improved therapies.


Multiple Sclerosis: Researchers have found a way to help the body help itself

Multiple Sclerosis: Researchers have found a way to help the body help itself
Posted on 24 Jan 2019 by Enviva Care

The exact cause of multiple sclerosis (MS) remains a mystery. We do, however, know that it is an autoimmune disease that attacks myelin – the protective coating of nerve cells – which eventually leads to the death of those nerve


Disease modifying drugs can reduce risk of secondary progressive MS

Disease modifying drugs can reduce risk of secondary progressive MS
Posted on 21 Jan 2019 by Enviva Care

According to a study of medical records, people with relapsing-remitting multiple sclerosis (MS) who begin early treatment with a disease-modifying drug have a lower risk of developing secondary progressive MS.


Navigation